TrialBee could save lives by bringing drugs to market faster
Big pharma still uses manual methods to recruit participants for drug trials, and that costs the industry money. Lots of money. The pharma industry loses $4.2 billion per year due to drug trial delays and $250K in lost sales per day that a new drug’s market launch is postponed. More importantly, delays in the approval of new treatments can also cost lives.
This is the problem that pre-launch startup TrialBee, one of the highlights of … Continue Reading
23andMe: Will the personal-genomics company need Big Pharma to make money?
Big pharma still uses manual methods to recruit participants for drug trials, and that costs the industry money. Lots of money. The pharma industry loses $4.2 billion per year due to drug trial delays and $250K in lost sales per day that a new drug’s market launch is postponed. More importantly, delays in the approval of new treatments can also cost lives.
This is the problem that pre-launch startup TrialBee, one of the highlights of … Continue Reading
Big Pharma's personalized-medicine consortium: Is it for real?
Big pharma still uses manual methods to recruit participants for drug trials, and that costs the industry money. Lots of money. The pharma industry loses $4.2 billion per year due to drug trial delays and $250K in lost sales per day that a new drug’s market launch is postponed. More importantly, delays in the approval of new treatments can also cost lives.
This is the problem that pre-launch startup TrialBee, one of the highlights of … Continue Reading
Is Big Pharma down for the count?
Big pharma still uses manual methods to recruit participants for drug trials, and that costs the industry money. Lots of money. The pharma industry loses $4.2 billion per year due to drug trial delays and $250K in lost sales per day that a new drug’s market launch is postponed. More importantly, delays in the approval of new treatments can also cost lives.
This is the problem that pre-launch startup TrialBee, one of the highlights of … Continue Reading
How drug reps do that thing they do
Big pharma still uses manual methods to recruit participants for drug trials, and that costs the industry money. Lots of money. The pharma industry loses $4.2 billion per year due to drug trial delays and $250K in lost sales per day that a new drug’s market launch is postponed. More importantly, delays in the approval of new treatments can also cost lives.
This is the problem that pre-launch startup TrialBee, one of the highlights of … Continue Reading
Patent fight: Tech vs. pharma, round one
Big pharma still uses manual methods to recruit participants for drug trials, and that costs the industry money. Lots of money. The pharma industry loses $4.2 billion per year due to drug trial delays and $250K in lost sales per day that a new drug’s market launch is postponed. More importantly, delays in the approval of new treatments can also cost lives.
This is the problem that pre-launch startup TrialBee, one of the highlights of … Continue Reading
Patent fight: Tech vs. pharma, round one
Big pharma still uses manual methods to recruit participants for drug trials, and that costs the industry money. Lots of money. The pharma industry loses $4.2 billion per year due to drug trial delays and $250K in lost sales per day that a new drug’s market launch is postponed. More importantly, delays in the approval of new treatments can also cost lives.
This is the problem that pre-launch startup TrialBee, one of the highlights of … Continue Reading
Is Big Pharma tiptoeing into embryonic stem cells?
Big pharma still uses manual methods to recruit participants for drug trials, and that costs the industry money. Lots of money. The pharma industry loses $4.2 billion per year due to drug trial delays and $250K in lost sales per day that a new drug’s market launch is postponed. More importantly, delays in the approval of new treatments can also cost lives.
This is the problem that pre-launch startup TrialBee, one of the highlights of … Continue Reading
Is Big Pharma tiptoeing into embryonic stem cells?
Big pharma still uses manual methods to recruit participants for drug trials, and that costs the industry money. Lots of money. The pharma industry loses $4.2 billion per year due to drug trial delays and $250K in lost sales per day that a new drug’s market launch is postponed. More importantly, delays in the approval of new treatments can also cost lives.
This is the problem that pre-launch startup TrialBee, one of the highlights of … Continue Reading
